Pancreatic cancer targets and uses thereof
US7473531B1 · kind B1 · utility
98Cited by
2References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 6, 2004 |
| Grant date | Jan 6, 2009 |
| Priority date | — |
| Expiry date | Oct 14, 2025 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T436/25
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention provides a method for diagnosing and detecting diseases associated with pancreas. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in pancreatic diseases (PCAT) and antibodies binds to PCAT. The present invention provides that PCAT is used as targets for screening agents that modulates the PCAT activities. Further, the present invention provides methods for treating diseases associated with pancreas.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.